Appco Pharma LLC

FDA Regulatory Profile

Summary

Total Recalls
6
510(k) Clearances
0
Inspections
13
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0420-2026Class IIPrazosin Hydrochloride Capsules, USP, 2mg, 100-count bottle, Rx Only, Manufactured for: Biocon PharMarch 27, 2026
D-0419-2026Class IIPrazosin Hydrochloride Capsules, USP, 1mg, 100-count bottle, Rx Only, Manufactured for: Biocon PharmMarch 27, 2026
D-0421-2026Class IIPrazosin Hydrochloride Capsules, USP, 5mg, 100-count bottle, Rx Only, Manufactured for: Biocon PharmMarch 27, 2026
D-0208-2025Class IIIVenlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC,January 16, 2025
D-0649-2020Class IIRanitidine Capsules 150 mg, (a) 60 count bottles (NDC 62559-690-60) , (b) 500 count bottles (NDC 625January 7, 2020
D-0648-2020Class IIRanitidine Capsules 300 mg, 30 count bottles. Rx only, Manufactured by: Appco Pharma LLC, PiscatawayJanuary 7, 2020